Initial SNP selection against regions with a high frequency of copy-number variation in the population, however, has recently been shown to impact the detection of this specific form of copy-number variation on these platforms.44 Besides Affymetrix and NimbleGen, companies such as Agilent and Illumina have also developed high-density genomic microarrays that can be used for CGH applications.24,31I